for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Moderna's COVID-19 vaccine shows promise against Delta variant in lab study

June 29 (Reuters) - Moderna Inc said on Tuesday its COVID-19 vaccine produced neutralizing antibodies against emerging variants, including the delta variant first identified in India, in a lab study.

Data was reported from blood serum from eight participants obtained one week after they received the second dose of the vaccine in an early-stage trial.

Reporting by Mrinalika Roy in Bengaluru; Editing by Arun Koyyur

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up